Legend Biotech Corp.

The 2025 American Society of Clinical Oncology conference will take place in Chicago from 30 May-3 June, and while it typically leans toward solid tumors, it also often features a number of important

Gene therapy-focused bluebird bio and its prospective buyers – private equity firms Carlyle and SK Capital Partners – are offering an additional option for bluebird shareholders to sell their stock, i

As Chinese biotech companies have faced a cash crunch at home, it has become necessary for them to look abroad for partnering opportunities to advance their assets through the clinic. This trend has l

Once almost written-off, GSK ’s Blenrep now looks like a practice-changing therapy for patients with relapsed/refractory multiple myeloma, after the company unveiled impressive Phase III overall surv